teva pharmaceuticals introduces the first generic glp-1 for weight loss Launches (Liraglutide) FDA Approves First Generic GLP-1

doi: 10.1093/jnen/nlab018 101 YumiYThomasMERobertW

Its strongest role is in abdominal body composition discussions because of its clinical connection to visceral adipose tissue reduction in adults with HIV-associated lipodystrophy

Realistic before-and-after results from AOD 9604 are gradual and better when paired with a structured nutrition and training plan

Protocol Notes One weekly retatrutide shot + 1-2 daily CJC/Ipa shots

Subjects who withdrew from the randomized withdrawal period and who did not provide efficacy data at their last on-treatment visit were classified as treatment failures (Study 6, Figure 5)